FDA Classifies Metoprolol Recall Covering 3,684 Bottles
The Food and Drug Administration has classified Advagen Pharma's recall of 3,684 bottles of metoprolol tartrate 50 milligram tablets as Class II after foreign tablets or capsules were found in bottles, and the agency reports no confirmed injuries.
Edited and fact-checked by Stephen Sprague
The recalled lot is 2611C065A1 with NDC 72888-210-00 and a May 2028 expiration, and patients who find a match should call their pharmacist before changing any dose.
Advagen Pharma Limited of East Windsor, New Jersey initiated the recall on October 27, 2026, and notified recipients by written letters. The recall covers 3,684 bottles of metoprolol tartrate 50 mg tablets, packed 1,000 tablets per bottle and distributed across the United States, and the FDA classified the action as Class II on November 10.
A pharmacist can settle a patient's question with three numbers printed on the bottle, because the lot is 2611C065A1, the National Drug Code is 72888-210-00 and the expiration date is May 2028. Bottles outside that lot are outside this recall, and the FDA report names no pharmacies, so the lot check is the only screen a patient at home can run.
The FDA gives one reason, the presence of foreign tablets or capsules inside the affected bottles, and the enforcement report stops there. It does not identify the foreign tablets, say how many a bottle may hold or explain how they entered the bottles, and it reports no confirmed patient injuries or adverse reactions, which leaves the central fact of this recall deliberately narrow.
Class II is the FDA's middle category, covering products whose use may cause temporary or medically reversible health consequences with a remote probability of serious harm. Metoprolol is a beta blocker prescribed for high blood pressure, chest pain and heart failure care, and the federal DailyMed label lists the 50 mg film-coated tablet, pink and scored and debossed R 50, among the drug's standard strengths.
Patients who find a lot match should call their pharmacist or prescriber before changing anything, because MedlinePlus warns that stopping metoprolol abruptly can raise the risk of chest pain and other cardiovascular problems. The safe sequence is a phone call first and a replacement bottle second, and an unidentified tablet found inside a prescription bottle should never be swallowed while the answer is pending.
The conversation.
Loading comments…
A little more perspective.
Reading is free. Verified members can comment and reply for $2 a month.